• Publications
  • Influence
Periprocedural myocardial infarction and injury in elective coronary stenting
Aims To assess the incidence, risk factors and prognosis of periprocedural myocardial infarction (MI) and myocardial injury in patients undergoing elective percutaneous coronary intervention (PCI).Expand
  • 49
  • 3
Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.
BACKGROUND Transcatheter left atrial appendage (LAA) occlusion is an alternative strategy for stroke prevention in patients with atrial fibrillation (AF). OBJECTIVES This study sought to determineExpand
  • 99
  • 2
  • PDF
Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions
Aims It remains unknown what percentage of patients treated with percutaneous coronary artery intervention (PCI) have high residual inflammatory risk (RIR). Moreover, the impact of RIR on clinicalExpand
  • 21
  • 1
Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention.
BACKGROUND Data on the impact of residual inflammatory risk (RIR) in patients undergoing percutaneous coronary intervention (PCI) with baseline low-density lipoprotein cholesterol (LDL-C) ≤70 mg/dlExpand
  • 10
  • 1
Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention
Objectives Contrast-induced acute kidney injury (CI-AKI) is a common and potentially severe complication in patients with ST elevation myocardial infarction (STEMI) treated with primary percutaneousExpand
  • 18
  • 1
Antithrombotic Therapy After Transcatheter Aortic Valve Replacement
The performance of transcatheter aortic valve replacement has expanded considerably during the past decade. Technological advances and refinement in implantation techniques have resulted in improvedExpand
  • 15
  • 1
Temporal trends, determinants, and impact of high‐intensity statin prescriptions after percutaneous coronary intervention: Results from a large single‐center prospective registry
Background High‐intensity statins (HIS) are recommended for secondary prevention following percutaneous coronary intervention (PCI). We aimed to describe temporal trends and determinants of HISExpand
  • 4
  • 1
Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation.
OBJECTIVES The aim of this study was to evaluate the long-term impact of coronary artery calcification (CAC) on outcomes after percutaneous coronary intervention and the respective performance ofExpand
  • 2
  • 1
Calculated Serum Osmolality, Acute Kidney Injury, and Relationship to Mortality after Percutaneous Coronary Intervention
Background: Data on the associations between serum osmolality (sOsmo) and acute kidney injury (AKI) as well as short- and long-term mortality in patients with coronary artery disease (CAD) undergoingExpand
  • 3
  • 1
Non‐femoral TAVR: Time to stratify alternative vascular approaches
Although transfemoral transcatheter aortic valve replacement (TAVR) is the gold standard, this approach is not be feasible in approximately 15% of the patients. Trans‐carotid TAVR may be lessExpand
  • 2
  • 1